StateofConfusion

Biotech in Review: Positive Consolidation in China Life Science Companies

I disagree with jturano, GNBT already has approval in India and some South American countries and will start sales. being in phase III is for the U.S and Canada and they have a proven product. Though there is some competition still working on products, some of the big pharmas have failed. Is the U.S. the only market in the world? NO and Generex should get their approvals. SciGen made a joint venture in essentially 2006. They are making a plant to produce insulin which Generex can obtain elsewhere if needed.

Generex Biotechnology: Oral-lyn Buccal Insulin Takes Center Stage

I have been a long term invester in Generex. Any biotech investor needs a lot of patients to hang in. This is a superior product from a great micro cap company and its delivery system can be used for other drugs as well. Other companies like Generex are NNVC and NNBP. All have great potential for the long term.